Metraipolis › archive › dc_64afdb53dd9a
Vitiligo: Ruxolitinib and Other Oral Treatment Options Beyond Ruxolitinib — Europe PMC PMID:41117150
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41117150
- DOI
- 10.1111/srt.70276
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T15:52:27.072Z
- SHA-256 of the archived text
19ce635e5a6292c19c25229ca0b7d7d10e862df534ae12fb687dc15e3f6abe6d- Stable URL of this page
https://metraipolis.com/documento/dc_64afdb53dd9a
How to cite
Vitiligo: Ruxolitinib and Other Oral Treatment Options Beyond Ruxolitinib — Europe PMC PMID:41117150 — Europe PMC (en), https://europepmc.org/article/MED/41117150 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_64afdb53dd9a (Metraipolis archive dc_64afdb53dd9a, sha256 19ce635e5a6292c19c25229ca0b7d7d10e862df534ae12fb687dc15e3f6abe6d)
BibTeX
@misc{dc64afdb53dd9a,
title = {Vitiligo: Ruxolitinib and Other Oral Treatment Options Beyond Ruxolitinib — Europe PMC PMID:41117150},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41117150},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_64afdb53dd9a; sha256 19ce635e5a6292c19c25229ca0b7d7d10e862df534ae12fb687dc15e3f6abe6d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41117150. Agents can read the archived copy with the MCP tool read_document.